Skip to main content

Table 1 Clinical features of 497 PRAD patient samples from the TCGA

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Characteristics Number (%)
Total   497
Age Median (range) 61 [41, 78]
PSA Median (range) 0.1 [0, 323]
Gleason score Primary + secondary  
  6 45
  7 247
  8 64
  9 137
  10 4
T stage T1 177
  T2 173
  T3 53
  T4 2
  NA 92
N stage N0 345
  N1 79
  NA 73
M stage M0 455
  M1 3
  NA 39
  1. PRAD prostate adenocarcinoma, NA not applicable